114 related articles for article (PubMed ID: 20645013)
21. The clinicopathological characteristics and genetic alterations of mucinous carcinoma of the stomach.
Tseng CH; Fang WL; Huang KH; Chen MH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
J Chin Med Assoc; 2020 Feb; 83(2):141-147. PubMed ID: 32015267
[TBL] [Abstract][Full Text] [Related]
22. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
23. Clinical Outcomes of Mucinous Gastric Carcinomas Compared with Non-mucinous and Signet Ring Cell Carcinomas.
Ahn H; Chung WC; Kim YJ; Ryu S; Lim E
Korean J Gastroenterol; 2020 Dec; 76(6):297-303. PubMed ID: 33199672
[TBL] [Abstract][Full Text] [Related]
24. Mucinous carcinomas of the colon and rectum. An analysis of 62 stage B and C lesions.
Connelly JH; Robey-Cafferty SS; Cleary KR
Arch Pathol Lab Med; 1991 Oct; 115(10):1022-5. PubMed ID: 1654871
[TBL] [Abstract][Full Text] [Related]
25. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
26. Clinicopathological study of mucinous gastric carcinoma.
Shibuya H; Nishida R; Koide S; Kurokawa J; Okita K
Ann Chir Gynaecol; 2000; 89(4):273-6. PubMed ID: 11204957
[TBL] [Abstract][Full Text] [Related]
27. Cell cycle regulators, APC/beta-catenin, NF-kappaB and Epstein-Barr virus in gastric carcinomas.
Kim B; Byun SJ; Kim YA; Kim JE; Lee BL; Kim WH; Chang MS
Pathology; 2010 Jan; 42(1):58-65. PubMed ID: 20025482
[TBL] [Abstract][Full Text] [Related]
28. [Comparison of the prognostic value of UICC and JGCA lymph node staging criteria for gastric cancer].
Pan Y; Liang H; Xue Q; Zhang RP; Cui QH; Liu N; Wang BG
Zhonghua Zhong Liu Za Zhi; 2008 May; 30(5):376-80. PubMed ID: 18953840
[TBL] [Abstract][Full Text] [Related]
29. c-MYC amplification in mucinous gastric carcinoma: a possible genetic alteration leading to deeply invasive tumors.
Choi JS; Seo J; Jung EJ; Kim EJ; Lee GK; Kim WH
Anticancer Res; 2012 Nov; 32(11):5031-7. PubMed ID: 23155275
[TBL] [Abstract][Full Text] [Related]
30. Reduction in membranous expression of beta-catenin and increased cytoplasmic E-cadherin expression predict poor survival in gastric cancer.
Ramesh S; Nash J; McCulloch PG
Br J Cancer; 1999 Dec; 81(8):1392-7. PubMed ID: 10604738
[TBL] [Abstract][Full Text] [Related]
31. Tumor size predicts survival in mucinous gastric carcinoma.
Sung CO; Lee SM; Choi JS; Kim KM; Choi MG; Noh JH; Sohn TS; Bae JM; Kim WH; Park CK; Kim S
J Surg Oncol; 2012 Nov; 106(6):757-64. PubMed ID: 22535583
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathological Characteristics and Prognosis of Mucinous Gastric Cancer.
Komori K; Kano K; Ando S; Watanabe H; Takahashi K; Maezawa Y; Fujikawa H; Sawazaki S; Numata M; Aoyama T; Yamada T; Tamagawa H; Yukawa N; Rino Y; Ogata T; Oshima T
Anticancer Res; 2023 Jun; 43(6):2865-2871. PubMed ID: 37247925
[TBL] [Abstract][Full Text] [Related]
33. [Characteristic of inflammatory infiltrate of gastric mucosa in patients with grade II-III gastric dysplasia and of stomach cancer].
Evtushenko VA; Vusik MV; Karakeshisheva MB; Pleshko RI; Ermolaeva LA
Klin Med (Mosk); 2008; 86(11):48-53. PubMed ID: 19177795
[TBL] [Abstract][Full Text] [Related]
34. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
Eom DW; Kang GH; Han SH; Cheon GJ; Han KH; Oh HS; Kim JH; Jang HJ; Hong SM
Am J Surg Pathol; 2011 Jan; 35(1):84-91. PubMed ID: 21164291
[TBL] [Abstract][Full Text] [Related]
35. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome.
Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD
Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225
[TBL] [Abstract][Full Text] [Related]
36. Mucin-producing gastric cancer: clinicopathological difference between signet ring cell carcinoma and mucinous carcinoma.
Fang WL; Wu CW; Lo SS; Chen JH; Hsieh MC; Shen KH; Li AF; Tai LC; Lui WY
Hepatogastroenterology; 2009; 56(93):1227-31. PubMed ID: 19760976
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic factors in advanced gastric carcinoma].
Amorosi A; Nannelli A
Arch De Vecchi Anat Patol; 1983 Jul; 65(2-3):323-37. PubMed ID: 6095769
[No Abstract] [Full Text] [Related]
38. [Epidemiological study, pathologic evaluation and prognostic factors of colorectal mucinous vs non-mucinous adenocarcinoma (a series of 196 patients)].
Arfaoui Toumi A; Kriaa Ben Mahmoud L; Khiari M; Lahmer A; Gharbi L; Dhraïef M; Khalfallah T; Regaya Mzabi S; Bouraoui S
Tunis Med; 2010 Jan; 88(1):12-7. PubMed ID: 20415207
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathologic features of gastric carcinoma patients who undergo a total gastrectomy.
Joo JK; Kim HG; Ryu SY; Lee JH; Kim DY
Int Surg; 2010; 95(2):147-52. PubMed ID: 20718322
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of protein expressions in primary and metastatic gastric carcinomas.
Kim JH; Kim MA; Lee HS; Kim WH
Hum Pathol; 2009 Mar; 40(3):314-22. PubMed ID: 18835621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
